14374: 30-day, Open-label, Active-controlled, Randomized Study of the Safety, Efficacy and the Pharmacokinetic and Pharmacodynamic Properties of Oral Rivaroxaban in Young Children with Various Manifestations of Venous Thrombosi

Project: Research project

Project Details

StatusFinished
Effective start/end date11/6/14 → 11/6/20

Funding

  • Bayer HealthCare Pharmaceuticals, Inc.